SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 17, 2019
LEGACY ACQUISITION, CORP.
(Exact name of registrant as specified in its charter)
|(State or other jurisdiction||(Commission File Number)||(IRS Employer|
|of incorporation)||Identification No.)|
1308 Race Street Suite 200
Cincinnati, Ohio 45202
(Address of principal executive offices, including zip code)
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|☐||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|☒||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|☐||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|☐||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Securities registered pursuant to Section 12(b) of the Act:
|Title of each class||Trading Symbol(s)||Name of each exchange on which registered|
|Units, each consisting of one share of Class A common stock and one Warrant to purchase one-half of one share of Class A common stock||LGC.U||New York Stock Exchange|
|Class A common stock, par value $0.0001 per share||LGC||New York Stock Exchange|
|Warrants, exercisable for one-half of one share of Class A common stock for $5.75 per half share, or $11.50 per whole share||LGC.WS||New York Stock Exchange|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement.
Amended Seller Note
In connection with the Amended and Restated Share Exchange Agreement, dated as of December 2, 2019 (the “Share Exchange Agreement”), between Legacy Acquisition Corp., a Delaware corporation (“Legacy” or the “Company”), and Blue Valor Limited, a company incorporated in Hong Kong (the “Seller”) and an indirect, wholly-owned subsidiary of Blue Focus Intelligent Communications Group Ltd. (the transaction contemplated by the Share Exchange Agreement, the “Business Combination”), on December 17, 2019, Legacy issued an amended and restated note (the “Amended Seller Note”) to the Seller that amended and restated the note, dated October 23, 2019, for the original principal amount of $979,155.40, issued by Legacy to the Seller (the “Original Seller Note”). Under the Amended Seller Note, Legacy increased the aggregate principal amount to $1,958,310.80 and provided for a process whereby Legacy may request additional borrowings under the Amended Seller Note. Borrowings under the Amended Seller Note will continue to bear interest at a rate equal to the 1 month USD LIBOR interest rate, plus 1.5% accruing from the date of the applicable borrowings. The Original Seller Note was issued in connection with the approval by Legacy’s stockholders of an amendment to Legacy’s amended and restated certificate of incorporation (the “Extension Amendment”) extending the date to which Legacy has to consummate a business combination from November 21, 2019 to December 21, 2019, with an option for Legacy to further extend such date up to five times (each an “Extension”), initially to January 21, 2020 and thereafter by up to four additional 30-day periods ending on May 20, 2020 (the “Extended Date”). The Amended Seller Note was issued in connection with the Extension of the date by which Legacy has to consummate a business combination from December 21, 2019, to January 21, 2020 (the “First Extension”).
Consistent with the Company’s proxy materials relating to the special meeting held on October 22, 2019, on December 19, 2019, Legacy made a cash contribution (“Contribution”) in respect of the First Extension to the trust account in an amount equal to $0.03 for each share Class A common stock then outstanding. As of December 19, 2019, there were 29,305,180 shares of Class A common stock issued and outstanding, which equaled an aggregate amount of $879,155.40.
Under the terms of the Share Exchange Agreement, the Seller agreed to loan (each, a “Seller Loan”) to Legacy the amount of the Contributions to be made by Legacy in connection with the Extension Amendment, and for each Extension thereafter; provided, however, that the Seller is not required to make any loan to Legacy with respect to any Extension for the purpose of consummating an initial business combination other than the Business Combination. In addition, the Seller agreed that the Seller Loans may include additional amounts to cover certain costs and expenses that Legacy will reasonably incur in connection with the continuation of operations until the earlier of the consummation of the Business Combination or the Extended Date and the total of all such costs and expenses shall not exceed a total of $300,000 in the aggregate for all Extensions through the Extended Date. No Seller Loan may exceed $1,000,000 in the aggregate (including loans to fund costs and expenses). The aggregate principal amount of $1,958,310.80 under the Amended Seller Note consists of (a) a new loan as of December 17, 2019 to fund the Company’s Contributions to the trust account of $879,155.40 as a result of the First Extension, plus $100,000 to fund the costs and expenses that Legacy reasonably expects to incur in connection with the continuation of operations until the earlier of the consummation of the Business Combination or the Extended Date, plus (b) the aggregate principal amount of the Original Seller Note (and all accrued interest thereon since the date of the initial Seller Loan).
The Seller Loans under the Amended Seller Note will continue to be forgiven by the Seller if the closing of the Business Combination does not occur and the trust account liquidates, except to the extent of any funds that are available to Legacy (i) after such liquidation in accordance with the trust agreement, or (ii) from any other source. The amount of the Seller Loans will be repayable by the Company to the Seller upon consummation of the Business Combination.
Should Legacy elect and/or the Seller request that Legacy further extend the date by which it has to consummate the Business Combination to February 20, 2020 or thereafter for up to three additional 30-day periods ending on the Extended Date, Legacy will publicly announce its decision no later than the close of business on the last day of the then-current Extension period. In addition, Legacy will make additional Contributions of $0.03 per outstanding public share for each period of the Extension by Legacy at its option and/or at the Seller’s request by up to four additional 30-day periods ending on the Extended Date. As a result, assuming the current number of shares of Class A common stock issued and outstanding, Legacy will make a Contribution in the amount of $879,155.40 to the trust account prior to the beginning of each Extension, which Contributions Legacy intends to borrow from the Seller under the terms of the Share Exchange Agreement. If, however, the Seller does not request an Extension to February 20, 2020 or any Extension thereafter and Legacy also determines not to make an additional Extension or its board of directors otherwise determines that it will not be able to consummate an initial business combination by the Extended Date and does not wish to have an additional Extension, Legacy’s board of directors would wind up its affairs and redeem 100% of the outstanding public shares.
A copy of the Amended Seller Note is filed as Exhibit 10.1 hereto and incorporated herein by reference.
Important Information About the Business Combination and Where to Find It
In connection with the proposed Business Combination, Legacy filed a preliminary proxy statement with the SEC on December 2, 2019, and intends to file a definitive proxy statement with the SEC. Legacy’s stockholders and other interested persons are advised to read the preliminary proxy statement and the amendments thereto and other relevant materials to be filed in connection with the Business Combination with the SEC, including, when available, a definitive proxy statement on Schedule 14A and documents incorporated by reference therein, as these materials will contain important information about the Business Combination. When available, the definitive proxy statement and other relevant materials for the Business Combination will be mailed to stockholders of Legacy as of a record date to be established for voting on the Business Combination. Stockholders will also be able to obtain copies of the preliminary proxy statements, the definitive proxy statements and other documents filed with the SEC that will be incorporated by reference therein, without charge, once available, at the SEC’s web site at www.sec.gov, or by directing a request to: Legacy Acquisition Corp., 1308 Race Street, Suite 200, Cincinnati, Ohio 45202, Attention: Secretary, (513) 618-7161.
Participants in the Solicitation
Legacy and its directors and executive officers may be deemed participants in the solicitation of proxies from Legacy’s stockholders with respect to the Business Combination. A list of the names of those directors and executive officers and a description of their interests in Legacy will be contained in Legacy’s definitive proxy statement that will be filed with respect to the Business Combination and in its annual report on Form 10-K for the fiscal year ended December 31, 2018, which was filed with the SEC and is available free of charge at the SEC’s web site at www.sec.gov, or by directing a request to: Legacy Acquisition Corp., 1308 Race Street, Suite 200, Cincinnati, Ohio 45202, Attention: Secretary, (513) 618-7161. Additional information regarding the interests of such participants will be contained in the proxy statement for the Business Combination when available.
The Seller, Blue Focus Intelligent Communications Group, and their respective directors and executive officers may also be deemed to be participants in the solicitation of proxies from the stockholders of Legacy in connection with the Business Combination. A list of the names of such directors and executive officers and information regarding their interests in the Business Combination will be included in Legacy’s definitive proxy statement that will be filed with respect to the Business Combination.
This Current Report on Form 8-K includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Legacy’s and the Blue Impact business’ actual results may differ from their expectations, estimates and projections and consequently, you should not rely on these forward looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “propose,” “plan,” “contemplate,” “may,” “will,” “shall,” “would,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” “positioned,” “goal,” “conditional” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Legacy’s expected Contributions to the trust account in respect of future Extensions (if any), Legacy’s intention to borrow the funds for any such Contributions from the Seller, and the timing of payment of any such Contributions.
These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside Legacy’s and the Blue Impact business’ control and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the Share Exchange Agreement, (2) the outcome of any legal proceedings that may be instituted against Legacy and other transaction parties following the announcement of the Share Exchange Agreement and the transactions contemplated therein; (3) the inability to complete the proposed Business Combination, including due to failure to obtain approval of the stockholders of Legacy or other conditions to closing in the Share Exchange Agreement; (4) the occurrence of any event, change or other circumstance that could otherwise cause the Business Combination to fail to close; (5) the receipt of an unsolicited offer from another party for an alternative business transaction that could interfere with the proposed Business Combination; (6) the risk that the proposed Business Combination disrupts current plans and operations as a result of the announcement and consummation of the proposed Business Combination; (7) costs related to the proposed Business Combination; (8) changes in applicable laws or regulations; (9) the aggregate number of Legacy shares requested to be redeemed by Legacy’s stockholders in connection with the proposed Business Combination; (10) the ability of the Blue Impact business to ameliorate or otherwise mitigate its existing material weaknesses and any material weaknesses in internal control over financial reporting or significant deficiencies that may be identified in the future; and (11) other risks and uncertainties indicated from time to time in the proxy statement relating to the proposed Business Combination, including those under “Risk Factors” therein, and in Legacy’s other filings with the SEC. Legacy cautions that the foregoing list of factors is not exhaustive. Legacy cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Legacy does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.
No Offer or Solicitation
This Current Report on Form 8-K shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Business Combination. This Current Report on Form 8-K shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of section 10 of the Securities Act, or an exemption therefrom.
Item 9.01 Financial Statements and Exhibits.
|10.1||Promissory Note dated as of December 17, 2019 issued by Legacy Acquisition Corp. to Blue Valor Limited.|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|LEGACY ACQUISITION CORP.|
|Dated: December 23, 2019||By:||/s/ William C. Finn|
|Name:||William C. Finn|
|Title:||Chief Financial Officer|
AMENDED AND RESTATED PROMISSORY NOTE
FOR VALUE RECEIVED, and subject to the terms and conditions set forth herein, Legacy Acquisition Corp., a Delaware corporation (the "Maker"), hereby unconditionally promises to pay to the order of Blue Valor Limited, a company incorporated in Hong Kong or its assigns (the "Noteholder," and together with the Maker, the "Parties"), the principal amounts set forth on Exhibit A attached hereto as it may be amended from time to time in accordance with the terms and conditions set forth herein (each such principal amount set forth on Exhibit A, a “Loan” and the sum of all such principal amounts set forth on Exhibit A, the "Total Loan Amount"), together with the Total Interest Amount (as defined below), as provided in this Amended and Restated Promissory Note (the "Note," as the same may be amended, restated, supplemented, or otherwise modified from time to time in accordance with its terms).
The Total Loan Amount is made by the Noteholder to the Maker pursuant to that Amended and Restated Share Exchange Agreement between the Parties dated as of December 2, 2019 (the “Amended and Restated Share Exchange Agreement” as the same may be amended, restated, supplemented, or otherwise modified from time to time in accordance with its terms). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to them in the Amended and Restated Share Exchange Agreement.
Maker and Noteholder are parties to that certain Promissory Note dated as of October 23, 2019 (the "Original Note Date") (the "Original Note"). At all times from the Original Note Date until the date hereof, the Original Note was in full force and effect, and the Parties desire to confirm that, except to the extent modified in this Note, all rights and obligations of the Parties in the Original Note remain in full force and effect as continuing obligations from and after the Original Note Date. The parties desire to amend and restate the Original Note in its entirety as set forth in this Note.
1. Definitions. The following capitalized terms shall have the meanings set forth in this Section 1.
“1 Month USD LIBOR Interest Rate” means the first LIBOR interest rate published each month from the date hereof until the Maturity Date.
"Applicable Rate" means the 1 Month USD LIBOR Interest Rate plus 1.5%.
"Default" means any of the events specified in Section 6 which constitute an Event of Default or which, upon the giving of notice, the lapse of time, or both, pursuant to Section 6 would, unless cured or waived, become an Event of Default.
"Event of Default" has the meaning set forth in Section 6.
"Loan" has the meaning set forth in the introductory paragraph.
"Loan Request" has the meaning set forth in Section 2.1.
"Maker" has the meaning set forth in the introductory paragraph.
"Maturity Date" means the date of the consummation of any initial business combination of Maker.
"Note" has the meaning set forth in the introductory paragraph.
"Noteholder" has the meaning set forth in the introductory paragraph.
"Original Note" has the meaning set forth in the second introductory paragraph.
"Original Note Date" has the meaning set forth in the second introductory paragraph.
"Parties" has the meaning set forth in the introductory paragraph.
"Total Interest Amount" has the meaning set forth in Section 3.1.
"Total Loan Amount" has the meaning set forth in the introductory paragraph.
2. Loan Requests; Final Payment Date; Optional Prepayments; Forgiveness.
2.1 Procedure for Loan Requests. On or before the 12th day of each month during the period commencing on the date hereof and continuing until the earlier of (i) April 12, 2020, (ii) the Maturity Date, or (iii) the date of forgiveness of the Total Loan Amount pursuant to Section 2.4 hereof, the Maker may submit a written notice to the Noteholder setting forth the requested loan amount in accordance with the terms and conditions of the Amended and Restated Share Exchange Agreement (the "Loan Request"). The Noteholder shall pay to the Maker the amount set forth in the Loan Request provided that the Loan Request complies with the requirements set forth in the Amended and Restated Share Exchange Agreement. The date of payment and the amount of each Loan paid by the Noteholder shall be inscribed by the Maker on Exhibit A attached to this Note and shall be delivered to the Noteholder on or about the time of the Noteholder’s payment of such Loan. Notwithstanding anything herein to the contrary, the Total Loan Amount at any given time shall equal the sum of all principal Loan amounts made by Noteholder to the Maker as of such time.
2.2 Final Payment Date. The aggregate unpaid principal amount of the Total Loan Amount, the Total Interest Amount, and all other amounts payable under this Note shall be due and payable on the Maturity Date, unless otherwise provided in Section 2.4 or Section 7.
2.3 Optional Prepayment. The Maker may prepay any Loan in whole or in part at any time or from time to time without penalty or premium by paying the principal amount of such Loan to be prepaid together with accrued interest thereon to the date of prepayment. No prepaid amount may be reborrowed.
2.4 Forgiveness. In the event that the Closing does not occur and the Trust Account liquidates, the principal amount of the Total Loan Amount under this Note shall be forgiven by the Noteholder, except to the extent of any funds that are available to Maker (i) after such liquidation in accordance with the Trust Agreement, or (ii) from any other source. For the avoidance of doubt, in such event, except as otherwise set forth in the foregoing sentence, the Noteholder, by acceptance of this Note, hereby irrevocably waives any claims it may have against the Trust Fund (including any distributions therefrom) now or in the future as a result of, or arising out of, any negotiations, contracts or agreements with the Purchaser and will not seek recourse against the Trust Fund (including any distributions therefrom) for any reason whatsoever.
3.1 Interest Rate. Except as otherwise provided herein, the outstanding principal amount of each Loan made hereunder shall bear interest at the Applicable Rate from the date such Loan was made (as set forth on Exhibit A attached hereto) until such Loan is (i) paid in full, whether at maturity, upon acceleration, by prepayment, or otherwise or (ii) forgiven as provided herein. Accordingly, accrued interest on each Loan shall be calculated separately as provided herein, and the sum of all accrued interest due on each Loan shall equal the total accrued interest for the Total Loan Amount (the "Total Interest Amount").
3.2 Interest Payment Dates. The Total Interest Amount shall be payable on the earlier to occur of (i) the Maturity Date, or (ii) the date that the principal amount of the Total Loan Amount under this Note is forgiven pursuant to Section 2.4 hereof.
3.3 Intentionally omitted.
3.4 Computation of Interest. All computations of interest shall be made on the basis of 365 or 366 days, as the case may be and the actual number of days elapsed. Interest shall accrue on each Loan on the day on which such Loan is made (as set forth on Exhibit A attached hereto), and shall not accrue on the Loan on the day on which it is paid.
3.5 Interest Rate Limitation. If at any time and for any reason whatsoever, the interest rate payable on any Loan shall exceed the maximum rate of interest permitted to be charged by the Noteholder to the Maker under applicable Law, such interest rate shall be reduced automatically to the maximum rate of interest permitted to be charged under applicable Law.
4. Payment Mechanics.
4.1 Manner of Payment. All payments of interest and principal shall be made in lawful money of the United States of America no later than 5:00 PM Eastern Standard Time on the date on which such payment is due by wire transfer of immediately available funds to the Noteholder's account at a bank specified by the Noteholder in writing to the Maker from time to time.
4.2 Business Day Convention. Whenever any payment to be made hereunder shall be due on a day that is not a Business Day, such payment shall be made on the next succeeding Business Day and such extension will be taken into account in calculating the amount of interest payable under this Note.
5. Representations and Warranties. The Maker hereby represents and warrants to the Noteholder on the date hereof as follows:
5.1 Existence. The Maker is a corporation, validly existing and in good standing under the laws of the state of its jurisdiction of organization.
5.2 Power and Authority. The Maker has the power and authority, and the legal right, to execute and deliver this Note and to perform its obligations hereunder.
5.3 Authorization; Execution and Delivery. The execution and delivery of this Note by the Maker and the performance of its obligations hereunder have been duly authorized by all necessary corporate action in accordance with all applicable Laws. The Maker has duly executed and delivered this Note.
5.4 No Approvals. No consent or authorization of, filing with, notice to, or other act by, or in respect of, any Authority or any other Person is required in order for the Maker to execute, deliver, or perform any of its obligations under this Note.
5.5 No Violations. The execution and delivery of this Note and the consummation by the Maker of the transactions contemplated hereby do not and will not (a) violate any provision of the Maker's organizational documents; (b) violate any Law or Order applicable to the Maker or by which any of its properties or assets may be bound; or (c) constitute a default under any material agreement or contract by which the Maker may be bound.
5.6 Enforceability. The Note is a valid, legal, and binding obligation of the Maker, enforceable against the Maker in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, or similar laws affecting the enforcement of creditors' rights generally and by general equitable principles (whether enforcement is sought by proceedings in equity or at law.
6. Events of Default. The occurrence of any of the following shall constitute an Event of Default hereunder:
6.1 Failure to Pay. The Maker fails to pay (a) any principal amount of any Loan when due; or (b) interest or any other amount when due and, in each case (with respect to (clause (a) and (b)), such failure continues for 5 days after written notice to the Maker.
6.2 Breach of Representations and Warranties. Any representation or warranty made or deemed made by the Maker to the Noteholder herein is incorrect in any material respect on the date as of which such representation or warranty was made or deemed made.
6.3 Breach of Covenants. The Maker fails to observe or perform any covenant, obligation, condition, or agreement contained in this Note, other than that specified in Section 6.1 and such failure continues for 30 days.
(a) the Maker commences any case, proceeding, or other action (i) under any existing or future law relating to bankruptcy, insolvency, reorganization, or other relief of debtors, seeking to have an order for relief entered with respect to it, or seeking to adjudicate it as bankrupt or insolvent, or seeking reorganization, arrangement, adjustment, winding-up, liquidation, dissolution, composition, or other relief with respect to it or its debts, or (ii) seeking appointment of a receiver, trustee, custodian, conservator, or other similar official for it or for all or any substantial part of its assets, or the Maker makes a general assignment for the benefit of its creditors;
(b) there is commenced against the Maker any case, proceeding, or other action of a nature referred to in Section 6.4(a) above which (i) results in the entry of an order for relief or any such adjudication or appointment or (ii) remains undismissed, undischarged, or unbonded for a period of 10 days;
(c) there is commenced against the Maker any case, proceeding, or other action seeking issuance of a warrant of attachment, execution, or similar process against all or any substantial part of its assets which results in the entry of an order for any such relief which has not been vacated, discharged, or stayed or bonded pending appeal within 10 days from the entry thereof;
(d) the Maker takes any action in furtherance of, or indicating its consent to, approval of, or acquiescence in, any of the acts set forth in Section 6.4(a), Section 6.4(b), or Section 6.4(c) above; or
(e) the Maker is generally not, or is unable to, or admits in writing its inability to, pay its debts as they become due.
6.5 Judgments. A judgment or decree is entered against the Maker and such judgment or decree has not been vacated, discharged, or stayed or bonded pending appeal within 10 days from the entry thereof.
7. Remedies. Upon the occurrence of an Event of Default and at any time thereafter during the continuance of such Event of Default, the Noteholder may at its option, by written notice to the Maker (a) declare the entire principal amount of the Total Loan Amount under this Note, together with the Total Interest Amount and all other amounts payable hereunder, immediately due and payable and/or (b) exercise any or all of its rights, powers, or remedies under applicable law; provided, however that, if an Event of Default described in Section 6.4 shall occur, the principal of the Total Loan Amount and the Total Interest Amount shall become immediately due and payable without any notice, declaration, or other act on the part of the Noteholder.
(a) All notices, requests, or other communications required or permitted to be delivered hereunder shall be delivered in writing, in each case to the address specified below or to such other address as such Party may from time to time specify in writing in compliance with this provision:
(i) If to the Maker:
Address: 1308 Race Street Suite 200 Cincinnati, Ohio 45202
Attn: Darryl McCall
Telephone: +1 (505) 820-0412, Facsimile: [NUMBER]
With a copy to:
Address: 1201 West Peachtree Street,
Suite 2800, Atlanta,
Attention: Gerry Williams
Telephone: +1 (404) 736-7891
(ii) If to the Noteholder:
Bldg. C9-C, Universal Creative Park,
9, Jiuxianqiao North Rd.,
Chaoyang District, Beijing 100015, China
Attn: Xin Wang, Finance Department
Telephone: +86(10) 5647 8811
With a copy to:
Greenberg Traurig LLP
Address: 200 Park Avenue, New York, New York 10166
Attention: Doron Lipshitz
Telephone: +1 (212) 801-3100
(b) Notices if (i) mailed by certified or registered mail or sent by hand or overnight courier service shall be deemed to have been given when received; (ii) sent by facsimile during the recipient's normal business hours shall be deemed to have been given when sent (and if sent after normal business hours shall be deemed to have been given at the opening of the recipient's business on the next business day); and (iii) sent by email shall be deemed received upon the sender's receipt of an acknowledgment from the intended recipient (such as by the "return receipt requested" function, as available, return email, or other written acknowledgment).
8.2 Expenses. In the event of a breach or default by Maker under this Note, the Maker shall reimburse the Noteholder on demand for all reasonable and documented out-of-pocket costs, expenses, and fees (including reasonable expenses and fees of its counsel) incurred by the Noteholder in connection with the enforcement of the Noteholder's rights hereunder.
8.3 Governing Law. This Note and any claim, controversy, dispute, or cause of action (whether in contract or tort or otherwise) based upon, arising out of, or relating to this Note, and the transactions contemplated hereby, shall be governed by the laws of the State of New York.
8.4 Submission to Jurisdiction.
(a) The Maker hereby irrevocably and unconditionally (i) agrees that any legal action, suit, or proceeding arising out of or relating to this Note may be brought in the courts of the State of New York or of the United States of America for the Southern District of New York and (ii) submits to the exclusive jurisdiction of any such court in any such action, suit, or proceeding. Final judgment against the Maker in any action, suit, or proceeding shall be conclusive and may be enforced in any other jurisdiction by suit on the judgment.
(b) Nothing in this Section 8.4 shall affect the right of the Noteholder to (i) commence legal proceedings or otherwise sue the Maker in any other court having jurisdiction over the Maker or (ii) serve process upon the Maker in any manner authorized by the laws of any such jurisdiction.
8.5 Venue. The Maker irrevocably and unconditionally waives, to the fullest extent permitted by applicable law, any objection that it may now or hereafter have to the laying of venue of any action or proceeding arising out of or relating to this Note in any court referred to in Section 8.4(b) and the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.
8.6 Waiver of Jury Trial. THE MAKER HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY RELATING TO THIS NOTE OR THE TRANSACTIONS CONTEMPLATED HEREBY WHETHER BASED ON CONTRACT, TORT, OR ANY OTHER THEORY.
8.7 Counterparts; Integration; Effectiveness. This Note and any amendments, waivers, consents, or supplements hereto may be executed in counterparts, each of which shall constitute an original, but all taken together shall constitute a single contract. This Note constitutes the entire contract between the Parties with respect to the subject matter hereof and supersede all previous agreements and understandings, oral or written, with respect thereto. Delivery of an executed counterpart of a signature page to this Note by facsimile or in electronic (i.e., "pdf" or "tif") format shall be effective as delivery of a manually executed counterpart of this Note.
8.8 Successors and Assigns. This Note may be assigned, transferred, or negotiated by the Noteholder to any Person, at any time, without notice to or the consent of the Maker. The Maker may not assign or transfer this Note or any of its rights hereunder without the prior written consent of the Noteholder, any such assignment without the Noteholder’s prior written consent shall be null and void. This Note shall inure to the benefit of and be binding upon the parties hereto and their permitted assigns.
8.9 Waiver of Notice. The Maker hereby waives presentment, demand for payment, protest, notice of dishonor, notice of protest or nonpayment, notice of acceleration of maturity, and diligence in connection with the enforcement of this Note or the taking of any action to collect sums owing hereunder.
8.10 Amendments and Waivers. No term of this Note may be waived, modified, or amended except by an instrument in writing signed by both of the parties hereto. Any waiver of the terms hereof shall be effective only in the specific instance and for the specific purpose given.
8.11 Headings. The headings of the various Sections and subsections herein are for reference only and shall not define, modify, expand, or limit any of the terms or provisions hereof.
8.12 No Waiver; Cumulative Remedies. No failure to exercise and no delay in exercising, on the part of the Noteholder, of any right, remedy, power, or privilege hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege. The rights, remedies, powers, and privileges herein provided are cumulative and not exclusive of any rights, remedies, powers, and privileges provided by law.
8.13 Severability. If any term or provision of this Note is invalid, illegal, or unenforceable in any jurisdiction, such invalidity, illegality, or unenforceability shall not affect any other term or provision of this Note or invalidate or render unenforceable such term or provision in any other jurisdiction.
[signature page follows]
IN WITNESS WHEREOF, the Maker has executed this Note as of December 17, 2019.
LEGACY ACQUISITION CORP.
|By:||/s/ Edwin J. Rigaud|
|Name: Edwin J. Rigaud|
|Title: Chairman & CEO|
(Signature Page to Amended and Restated Promissory Note)
|Loan Number||Loan Date||Pricipal Amount of Loan|
|1||October 24, 2019||$979,155.40|
|2||December 18, 2019||$979,155.40|
(Exhibit A to Amended and Restated Promissory Note)